These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20363716)

  • 1. Environmental factors and nosology of the endocrine system.
    Dacou-Voutetakis C
    Hormones (Athens); 2010; 9(1):7-8. PubMed ID: 20363716
    [No Abstract]   [Full Text] [Related]  

  • 2. Definition, classification and mechanism of action of endocrine disrupting chemicals.
    Wuttke W; Jarry H; Seidlova-Wuttke D
    Hormones (Athens); 2010; 9(1):9-15. PubMed ID: 20363717
    [No Abstract]   [Full Text] [Related]  

  • 3. Environmental estrogens and endocrine disruption: importance of comparative endocrinology.
    Foster WG
    Endocrinology; 2008 Sep; 149(9):4267-8. PubMed ID: 18511513
    [No Abstract]   [Full Text] [Related]  

  • 4. Endocrine disruptors.
    Pombo M; Castro-Feijóo L
    J Pediatr Endocrinol Metab; 2005 Dec; 18 Suppl 1():1145-55. PubMed ID: 16398443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of endocrine disruption.
    Patisaul HB; Fenton SE; Aylor D
    Best Pract Res Clin Endocrinol Metab; 2018 Jun; 32(3):283-297. PubMed ID: 29779582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxic effects of endocrine disruptors.
    Laessig SA; McCarthy MM; Silbergeld EK
    Curr Opin Neurol; 1999 Dec; 12(6):745-51. PubMed ID: 10676759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction: The ecological relevance of chemically induced endocrine disruption in wildlife.
    Jobling S; Tyler CR
    Environ Health Perspect; 2006 Apr; 114 Suppl 1(Suppl 1):7-8. PubMed ID: 16818239
    [No Abstract]   [Full Text] [Related]  

  • 8. The endocrine disrupters: a major medical challenge.
    Amaral Mendes JJ
    Food Chem Toxicol; 2002 Jun; 40(6):781-8. PubMed ID: 11983272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings of the 5th Copenhagen Workshop on Endocrine Disrupters: Ubiquitous endocrine disrupters and possible human health effects, 20-22 May 2009.
    Int J Androl; 2010 Apr; 33(2):251-474. PubMed ID: 20806455
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings of the 5th Copenhagen Workshop on endocrine disrupters: ubiquitous endocrine disrupters and possible human health effects. Preface.
    Andersson AM; Bay K; Grigor KM; Toppari J; Skakkebaek NE
    Int J Androl; 2010 Apr; 33(2):251. PubMed ID: 20487041
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction to "screening for endocrine activity-experiences with the US EPA's endocrine disruptor screening program and future considerations".
    Marty S
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):1-2. PubMed ID: 24510782
    [No Abstract]   [Full Text] [Related]  

  • 12. Reproducibility of endocrine disruption data.
    Ashby J; Elliott BM
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):94-5. PubMed ID: 9339485
    [No Abstract]   [Full Text] [Related]  

  • 13. Receptors mediating toxicity and their involvement in endocrine disruption.
    Rüegg J; Penttinen-Damdimopoulou P; Mäkelä S; Pongratz I; Gustafsson JA
    EXS; 2009; 99():289-323. PubMed ID: 19157066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of nanomaterials as endocrine disruptors.
    Iavicoli I; Fontana L; Leso V; Bergamaschi A
    Int J Mol Sci; 2013 Aug; 14(8):16732-801. PubMed ID: 23949635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationships for endocrine disruptors: what we know and what we don't know.
    Lucier GW
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):34-5. PubMed ID: 9339476
    [No Abstract]   [Full Text] [Related]  

  • 16. Endocrine disruption: historical perspectives and its impact on the future of toxicology testing.
    Marty MS; Carney EW; Rowlands JC
    Toxicol Sci; 2011 Mar; 120 Suppl 1():S93-108. PubMed ID: 20974704
    [No Abstract]   [Full Text] [Related]  

  • 17. What are the health concerns about BPA?
    Mayo Clin Womens Healthsource; 2010 Jul; 14(7):8. PubMed ID: 20517192
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program.
    Borgert CJ; Mihaich EM; Ortego LS; Bentley KS; Holmes CM; Levine SL; Becker RA
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):185-91. PubMed ID: 21803110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction--workshop on characterizing the effects of endocrine disruptors on human health at environmental exposure levels.
    Melnick RL
    Environ Health Perspect; 1999 Aug; 107 Suppl 4(Suppl 4):603-4. PubMed ID: 10421769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of endocrine disruptors on endocrine targets.
    Diamanti-Kandarakis E; Palioura E; Kandarakis SA; Koutsilieris M
    Horm Metab Res; 2010 Jul; 42(8):543-52. PubMed ID: 20419622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.